{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:13:39Z","timestamp":1787678019394,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007231","name":"Cancer Society in Stockholm","doi-asserted-by":"publisher","award":["141382"],"award-info":[{"award-number":["141382"]}],"id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["150371"],"award-info":[{"award-number":["150371"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Swedish Childhood Cancer Foundation","doi-asserted-by":"publisher","award":["PR2014-0109"],"award-info":[{"award-number":["PR2014-0109"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["521-2014-2258"],"award-info":[{"award-number":["521-2014-2258"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["16-04-00768\u0410"],"award-info":[{"award-number":["16-04-00768\u0410"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-15-00463"],"award-info":[{"award-number":["14-15-00463"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-25-00056"],"award-info":[{"award-number":["14-25-00056"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbamcr.2016.12.016","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T12:20:49Z","timestamp":1482063649000},"page":"498-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Contrasting effects of glutamine deprivation on apoptosis induced by conventionally used anticancer drugs"],"prefix":"10.1016","volume":"1864","author":[{"given":"Kadri","family":"Valter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Kruspig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Maximchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengmin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Zhivotovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Gogvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2016.12.016_bb0005","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ijrobp.2007.07.2343","article-title":"Enhanced response of human head and neck cancer xenograft tumors to cisplatin combined with 2-deoxy-d-glucose correlates with increased 18F-FDG uptake as determined by PET imaging","volume":"69","author":"Simons","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0015","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","article-title":"Energy metabolism in tumor cells","volume":"274","author":"Moreno-Sanchez","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gde.2008.02.003","article-title":"Brick by brick: metabolism and tumor cell growth","volume":"18","author":"DeBerardinis","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0030","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","article-title":"Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport","volume":"56","author":"Yang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0040","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.molcel.2012.05.043","article-title":"Glutaminolysis activates Rag-mTORC1 signaling","volume":"47","author":"Duran","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0050","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0055","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","article-title":"Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition","volume":"126","author":"Jacque","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting mitochondrial glutaminase activity inhibits oncogenic transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0065","doi-asserted-by":"crossref","first-page":"38440","DOI":"10.18632\/oncotarget.6301","article-title":"Q-ing tumor glutaminase for therapy","volume":"6","author":"Stine","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0070","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.3390\/ijms160922830","article-title":"Targeting glutamine induces apoptosis: a cancer therapy approach","volume":"16","author":"Chen","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0075","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng1097-141","article-title":"KILLER\/DR5 is a DNA damage-inducible p53-regulated death receptor gene","volume":"17","author":"Wu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0085","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/jbc.274.3.1541","article-title":"The role of c-FLIP in modulation of CD95-induced apoptosis","volume":"274","author":"Scaffidi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/eji.200636956","article-title":"c-FLIP(S) reduces activation of caspase and NF-kappaB pathways and decreases T cell survival","volume":"38","author":"Hinshaw-Makepeace","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0095","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1074\/jbc.C000569200","article-title":"Phosphatidylinositol 3-kinase\/Akt activity regulates c-FLIP expression in tumor cells","volume":"276","author":"Panka","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0100","first-page":"5897","article-title":"Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines","volume":"62","author":"Harada","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0105","first-page":"1849","article-title":"Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL","volume":"25","author":"Johnsen","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40170-015-0137-1","article-title":"Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ss-lapachone","volume":"3","author":"Chakrabarti","year":"2015","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1074-7613(00)80400-8","article-title":"Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway","volume":"7","author":"Chaudhary","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.15430\/JCP.2013.18.3.221","article-title":"Oncogenes and tumor suppressors regulate glutamine metabolism in cancer cells","volume":"18","author":"Kim","year":"2013","journal-title":"J. Cancer Prev."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1207\/s15327914nc5402_13","article-title":"Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine","volume":"54","author":"Todorova","year":"2006","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.200703099","article-title":"Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells","volume":"178","author":"Yuneva","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0135","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ncb866","article-title":"BID regulation by p53 contributes to chemosensitivity","volume":"4","author":"Sax","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0145","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/molehr\/4.12.1099","article-title":"The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death","volume":"4","author":"Basu","year":"1998","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ncb0504-386","article-title":"Fatal liaisons of p53 with Bax and Bak","volume":"6","author":"Perfettini","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0155","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1097-2765(03)00050-9","article-title":"p53 has a direct apoptogenic role at the mitochondria","volume":"11","author":"Mihara","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0165","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3109\/10715762.2011.591391","article-title":"Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells","volume":"45","author":"Itoh","year":"2011","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0170","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1038\/cddis.2014.35","article-title":"Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L)","volume":"5","author":"Min","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0175","article-title":"Gambogic acid enhances the radiosensitivity of human esophageal cancer cells by inducing reactive oxygen species via targeting Akt\/mTOR pathway","author":"Yang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0180","doi-asserted-by":"crossref","first-page":"e0122753","DOI":"10.1371\/journal.pone.0122753","article-title":"Streptococcus pneumoniae induces autophagy through the inhibition of the PI3K-I\/Akt\/mTOR pathway and ROS hypergeneration in A549 cells","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0185","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.freeradbiomed.2009.05.024","article-title":"ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells","volume":"47","author":"Cao","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mi.3.3.124","article-title":"Targeting the FLICE inhibitory protein (FLIP) in cancer therapy","volume":"3","author":"Wajant","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0195","first-page":"176","article-title":"c-FLIP, a master anti-apoptotic regulator","volume":"34","author":"Safa","year":"2012","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0200","doi-asserted-by":"crossref","first-page":"27345","DOI":"10.1074\/jbc.M504019200","article-title":"Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail","volume":"280","author":"Poukkula","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0205","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","article-title":"Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells","volume":"161","author":"Griffith","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1521-4141(200001)30:1<155::AID-IMMU155>3.0.CO;2-X","article-title":"Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP","volume":"30","author":"Wang","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbamcr.2016.12.016_bb0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000086599","article-title":"TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase\/Akt through the short form of cellular FLIP and Bcl-2","volume":"42","author":"Alladina","year":"2005","journal-title":"J. Vasc. Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016748891630341X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016748891630341X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:03:54Z","timestamp":1692612234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016748891630341X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S016748891630341X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.12.016","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contrasting effects of glutamine deprivation on apoptosis induced by conventionally used anticancer drugs","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2016.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}